Form 8-K - Current report:
SEC Accession No. 0001213900-26-082876
Filing Date
2026-07-29
Accepted
2026-07-29 17:00:57
Documents
11
Period of Report
2026-07-23
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0299692-8k_ostherapies.htm   iXBRL 8-K 24436
  Complete submission text file 0001213900-26-082876.txt   191101

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ostx-20260723.xsd EX-101.SCH 3023
3 XBRL LABEL FILE ostx-20260723_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ostx-20260723_pre.xml EX-101.PRE 22364
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0299692-8k_ostherapies_htm.xml XML 3339
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 261218731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)